Skip to content
Medical Health Aged Care

Dementia Australia supports Tamworth

Dementia Australia 2 mins read

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support in Tamworth between 11-14 September 2023.

It is estimated there are almost 135,000 people living with dementia in New South Wales. Without a medical breakthrough this number is expected to increase to more than 260,000 people living with dementia by 2058.

The Dementia Australia sessions are an opportunity for people living with dementia, their carers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. Please note, bookings are essential.

Carer Wellness Program

This group session is designed to support positive health and wellbeing outcomes for a carer, family or friend of a person living with dementia.

  • Monday 11 September 9:30am-3pm


Understanding Dementia

This session provides an introduction to dementia including an overview of the different types of dementia, diagnosis, planning ahead and how to support someone living with dementia.

  • Tuesday 12 September 9:30am-11:30am


It starts with you

If you are passionate about your local community and want to make it more dementia-friendly then this session is for you

  • Tuesday 12 September 11:30am-12:30pm


Mild Cognitive Impairment

This session provides information about mild cognitive impairment, including diagnosis, progression, treatment and management strategies.

  • Wednesday 13 September 10am-12pm


Communication and Dementia

This session provides information on dementia, the way we communicate and how changes in communication can occur as a result of dementia.

  • Wednesday 13 September 1pm-3pm

EDIE for Family Carers

This session enhances knowledge of dementia through virtual reality technology that allows participants to see the world through the eyes of a person living with dementia.

  • Thursday 14 September 1:30pm-4:30pm


Understanding Changes in Behaviours

This session provides an introduction to dementia and changes to the brain, effects on behaviour and the impacts of changed behaviour.

  • Thursday 14 September 1:30pm-4:30pm

 

Bookings are essential. Visit www.dementia.org.au/brainhub/tamworth for details and to register. You can also call the National Dementia Helpline to register for this course on 1800 100 500. The National Dementia Helpline is available 24 hours a day, seven days a week.

 

Dementia Australia is the source of trusted information, education and services for the estimated more than 400,000 Australians living with dementia, and the more than 1.5 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

-Ends-

Media contacts: Megan Jones, Media & Communications Advisor, [email protected],0411 461 678

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

 

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.